DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Kubitza D, Becka M, Mueck W. et al.
Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct factor Xa inhibitor.
Br J Clin Pharmacol 2010;
70 (05) 703-712
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.